KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Oscar Health (OSCR) Share-based Compensation (2020 - 2025)

Historic Share-based Compensation for Oscar Health (OSCR) over the last 6 years, with Q4 2025 value amounting to $18.1 million.

  • Oscar Health's Share-based Compensation fell 3005.22% to $18.1 million in Q4 2025 from the same period last year, while for Dec 2025 it was $87.7 million, marking a year-over-year decrease of 2018.68%. This contributed to the annual value of $87.7 million for FY2025, which is 2018.68% down from last year.
  • Oscar Health's Share-based Compensation amounted to $18.1 million in Q4 2025, which was down 3005.22% from $20.5 million recorded in Q3 2025.
  • In the past 5 years, Oscar Health's Share-based Compensation registered a high of $71.5 million during Q1 2023, and its lowest value of $18.1 million during Q4 2025.
  • Over the past 5 years, Oscar Health's median Share-based Compensation value was $26.6 million (recorded in 2022), while the average stood at $27.8 million.
  • In the last 5 years, Oscar Health's Share-based Compensation skyrocketed by 18324.41% in 2021 and then tumbled by 6371.02% in 2024.
  • Oscar Health's Share-based Compensation (Quarter) stood at $28.3 million in 2021, then increased by 2.9% to $29.1 million in 2022, then fell by 10.13% to $26.1 million in 2023, then decreased by 1.1% to $25.9 million in 2024, then crashed by 30.05% to $18.1 million in 2025.
  • Its Share-based Compensation stands at $18.1 million for Q4 2025, versus $20.5 million for Q3 2025 and $24.1 million for Q2 2025.